Literature DB >> 8132183

Occlusive patch method for skin sensitization in guinea pigs: the Buehler method.

E V Buehler1.   

Abstract

Currently, the European Community is in the process of discussing the details of how to conduct various protocols for safety assessment. Additionally, there is a desire that these protocols be harmonized internationally. This presentation attempts to describe the critical and non-critical parameters of the protocol for detecting potential contact allergens in the guinea pig and also discusses some controversial issues. It is also emphasized that the identification of a test material as a potential sensitizer is only the first step in the risk-assessment exercise.

Entities:  

Mesh:

Year:  1994        PMID: 8132183     DOI: 10.1016/0278-6915(94)90169-4

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  4 in total

Review 1.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

2.  Mitigation of nitrogen mustard mediated skin injury by a novel indomethacin bifunctional prodrug.

Authors:  Gabriella M Composto; Jeffrey D Laskin; Debra L Laskin; Donald R Gerecke; Robert P Casillas; Ned D Heindel; Laurie B Joseph; Diane E Heck
Journal:  Exp Mol Pathol       Date:  2016-05-14       Impact factor: 3.362

3.  In vivo evaluation of a transdermal codrug of 6-beta-naltrexol linked to hydroxybupropion in hairless guinea pigs.

Authors:  Paul K Kiptoo; Kalpana S Paudel; Dana C Hammell; Mohamed O Hamad; Peter A Crooks; Audra L Stinchcomb
Journal:  Eur J Pharm Sci       Date:  2008-01-31       Impact factor: 4.384

4.  Correlating the structure and reactivity of a contact allergen, DNCB, and its analogs to sensitization potential.

Authors:  Flora Kimani; Seong-Min Kim; Rachel Steinhardt; Aaron P Esser-Kahn
Journal:  Bioorg Med Chem       Date:  2019-05-11       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.